Nothing Special   »   [go: up one dir, main page]

ATE203023T1 - Tropanderivate, deren herstellung und verwendung - Google Patents

Tropanderivate, deren herstellung und verwendung

Info

Publication number
ATE203023T1
ATE203023T1 AT97903355T AT97903355T ATE203023T1 AT E203023 T1 ATE203023 T1 AT E203023T1 AT 97903355 T AT97903355 T AT 97903355T AT 97903355 T AT97903355 T AT 97903355T AT E203023 T1 ATE203023 T1 AT E203023T1
Authority
AT
Austria
Prior art keywords
derivatives
disorders
tropande
production
monoamine neurotransmitter
Prior art date
Application number
AT97903355T
Other languages
English (en)
Inventor
Joergen Scheel-Krueger
Peter Moldt
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE203023T1 publication Critical patent/ATE203023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97903355T 1996-02-22 1997-02-21 Tropanderivate, deren herstellung und verwendung ATE203023T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK19496 1996-02-22
PCT/EP1997/000850 WO1997030997A1 (en) 1996-02-22 1997-02-21 Tropane-derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
ATE203023T1 true ATE203023T1 (de) 2001-07-15

Family

ID=8090830

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903355T ATE203023T1 (de) 1996-02-22 1997-02-21 Tropanderivate, deren herstellung und verwendung

Country Status (32)

Country Link
US (3) US6288079B1 (de)
EP (2) EP1130020A1 (de)
JP (1) JP3238414B2 (de)
KR (1) KR100446571B1 (de)
CN (1) CN1077574C (de)
AT (1) ATE203023T1 (de)
AU (1) AU720358B2 (de)
BG (1) BG63945B1 (de)
BR (1) BR9707636A (de)
CA (1) CA2244773C (de)
CZ (1) CZ287007B6 (de)
DE (1) DE69705608T2 (de)
DK (1) DK0885220T3 (de)
EE (1) EE04751B1 (de)
ES (1) ES2159839T3 (de)
GR (1) GR3036829T3 (de)
HK (1) HK1018957A1 (de)
HU (1) HU228356B1 (de)
IL (1) IL125146A (de)
IS (1) IS1824B (de)
NO (1) NO318731B1 (de)
NZ (1) NZ330886A (de)
PL (1) PL185132B1 (de)
PT (1) PT885220E (de)
RU (1) RU2167876C2 (de)
SG (1) SG99853A1 (de)
SI (1) SI0885220T1 (de)
SK (1) SK281813B6 (de)
TR (1) TR199801641T2 (de)
UA (1) UA49872C2 (de)
WO (1) WO1997030997A1 (de)
ZA (1) ZA971525B (de)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486323B1 (en) * 1998-09-30 2002-11-26 Nihon Medi-Physics Co., Ltd. Process for producing optically active tropinonemonocarboxylic acid derivative
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
EP1397358A1 (de) * 2001-05-23 2004-03-17 Neurosearch A/S Tropanderivate und deren verwendung als monoamin-neurotransmitter-wiederaufnahmehemmer
CA2506646A1 (en) * 2001-10-11 2003-04-11 Organix, Inc. Serotonin transport inhibitors
US20030114475A1 (en) * 2001-10-31 2003-06-19 Addiction Therapies, Inc. Methods for the treatment of addiction
ATE345135T1 (de) 2001-11-30 2006-12-15 Neurosearch As Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
US7459464B2 (en) 2002-05-30 2008-12-02 Neurosearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
EP1560813B1 (de) 2002-11-01 2010-03-17 NeuroSearch A/S Neue piperidinderivate und deren verwendung als monoaminneurotransmitter-wiederaufnahmehemmer
AU2003302609B9 (en) 2002-12-02 2008-05-15 Xenome Ltd Novel chi-conotoxin peptides (-I)
EP2412719A1 (de) 2002-12-02 2012-02-01 Xenome Ltd Chi-Conotoxin-Peptide
CN100372850C (zh) * 2003-02-12 2008-03-05 神经研究公司 新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
MXPA05008315A (es) 2003-02-12 2005-09-20 Neurosearch As Nuevos derivados de 8-aza-biciclo[3.2.1]octano y su uso como inhibidores de reabsorcion del neurotransmisor de monoamina.
US7247643B2 (en) 2003-02-12 2007-07-24 Neurosearch A/S 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN100551924C (zh) * 2003-02-12 2009-10-21 神经研究公司 8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
WO2004113334A1 (en) * 2003-06-24 2004-12-29 Neurosearch A/S Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
AR045141A1 (es) * 2003-07-31 2005-10-19 Neurosearch As Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas.
AU2004278158B2 (en) 2003-10-03 2009-08-13 Pfizer Inc. Imidazopyridine substituted tropane derivatives with CCR5 receptor antagonist activity for the treatment of HIV and inflammation
CA2542442C (en) * 2003-10-16 2012-08-21 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor
WO2005049024A2 (de) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Feste pharmazeutische zubereitungsform
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
EP1708707A1 (de) * 2004-01-22 2006-10-11 Neurosearch A/S Pharmazeutische zusammensetzung mit einem monoamin-neurotransmitter-wiederaufnahmehemmer und einem n-methyl-d-aspartat (nmda)-rezeptorantagonisten
EP1727547A1 (de) * 2004-01-22 2006-12-06 Neurosearch A/S Verbindungen für die anhaltende verringerung des körpergewichts
DE102004004965B4 (de) * 2004-01-31 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates
EP1755602A1 (de) * 2004-06-04 2007-02-28 Neurosearch A/S Monoamin-neurotransmitter-wiederaufnahmehemmer zur hemmung von beta-amyloid (ein beta 40 und ein beta 42) -erzeugung
JP2008502650A (ja) * 2004-06-18 2008-01-31 ノイロサーチ アクティーゼルスカブ 新規な９−アザ−ビシクロ［３．３．１］ノナン誘導体及びこれらのモノアミン神経伝達物質再取り込み阻害剤としての使用
US7524958B2 (en) 2004-06-18 2009-04-28 Neurosearch A/S Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2570075A1 (en) 2004-06-18 2005-12-29 Neurosearch A/S Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
KR20070061846A (ko) 2004-09-30 2007-06-14 뉴로서치 에이/에스 신규한 크로멘-2-온 유도체 및 모노아민 신경전달물질재흡수 억제제로서의 이의 용도
WO2006035034A1 (en) * 2004-09-30 2006-04-06 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US7923444B2 (en) 2005-02-10 2011-04-12 Neurosearch A/S Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2006106090A1 (en) * 2005-04-04 2006-10-12 Neurosearch A/S Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP2272847A1 (de) 2005-04-08 2011-01-12 NeuroSearch A/S Enantiomere und deren Verwendung als Monoamin-Neurotransmitter-Wiederaufnahmehemmer
US7943630B2 (en) * 2005-06-28 2011-05-17 Neurosearch A/S 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2007000465A1 (en) * 2005-06-28 2007-01-04 Neurosearch A/S Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
ATE481386T1 (de) * 2005-06-28 2010-10-15 Neurosearch As Neue 3-aza-spiroä5.5üundec-8-en derivate und deren verwendung als inhibitoren der wiederaufnahme von monoaminneurotransmittern
WO2007000464A1 (en) * 2005-06-28 2007-01-04 Neurosearch A/S Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2007006738A2 (en) * 2005-07-12 2007-01-18 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 2 , 3-disubstituted tropanes for the treatment of disorders of sexual desire
BRPI0613403A2 (pt) 2005-07-15 2009-02-10 Amr Technology Inc tetrahidrobenzodiazepinas aril- e heteroarila-substituÍdas e uso das mesmas para bloquear a recaptaÇço de norepinefrina, dopamina e serotonina
WO2007025055A2 (en) 2005-08-24 2007-03-01 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Benztropine compounds and uses thereof as dopamine uptake inhibitors
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
EP1779851A1 (de) * 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Behandlung von Diabetes
TW200804367A (en) 2005-11-11 2008-01-16 Neurosearch As Novel compounds
AU2007213669A1 (en) 2006-02-10 2007-08-16 Neurosearch A/S 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200800980A (en) * 2006-02-17 2008-01-01 Neurosearch As Novel compounds
EP2255848A3 (de) 2006-09-04 2011-04-06 NeuroSearch AS Pharmazeutische Kombinationen von Nicotin Rezeptor Modulatoren und Agenzien zur Verbesserung der kognitiven Fähigkeiten
EP2064186A1 (de) * 2006-09-11 2009-06-03 Glaxo Group Limited Azabicyclische verbindungen als inhibitoren der monoamin-wiederaufnahme
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
TW200904815A (en) 2007-05-09 2009-02-01 Neurosearch As Novel compounds
US20100286195A1 (en) * 2007-09-10 2010-11-11 Neurosearch A/S Novel benzooxazol-and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
EP2201005A1 (de) * 2007-09-10 2010-06-30 Neurosearch A/S Neue phenoxazin-3-on-derivate und ihre verwendung als monoamin-neurotransmitter-wiederaufnahmeinhibitoren
US20100286194A1 (en) * 2007-11-20 2010-11-11 Neurosearch A/S Method for treating addiction
WO2009065845A1 (en) * 2007-11-20 2009-05-28 Neurosearch A/S A method for treating over-eating disorders
ES2662072T3 (es) 2009-05-12 2018-04-05 Albany Molecular Research, Inc. 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y uso de la misma
ES2528404T3 (es) 2009-05-12 2015-02-10 Bristol-Myers Squibb Company Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos
MX2011011904A (es) 2009-05-15 2011-12-08 Neurosearch As Derivados de cromen-2-ona y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina.
US20120220604A1 (en) 2009-09-21 2012-08-30 Neurosearch A/S Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011092061A1 (en) 2010-01-29 2011-08-04 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 (en) 2010-03-25 2011-09-29 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US8153653B2 (en) * 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
WO2012000881A1 (en) 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US8722662B2 (en) 2010-10-07 2014-05-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
CN108434129A (zh) 2012-02-16 2018-08-24 萨尼奥纳有限责任公司 用于联合治疗的药物组合物
CN107666913B (zh) 2015-03-03 2021-11-26 萨尼奥纳有限责任公司 特索芬辛，β-受体阻滞剂组合制剂
EA026727B1 (ru) * 2015-09-10 2017-05-31 Замертон Холдингс Лимитед Соль (1r,2r,3s)-3-(3,4-дихлорфенил)-2-(этоксиметил)-8-метил-8-азабицикло[3.2.1]октана и фталевой кислоты, способ её получения, продукт способа, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способы лечения и/или профилактики нарушений, связанных с ожирением
EP3402473A1 (de) 2016-01-15 2018-11-21 Saniona A/S Tesofensin und metoprolol zur behandlung von hypertonie
EA028995B1 (ru) * 2016-02-25 2018-01-31 Замертон Холдингс Лимитед Соль тезофензина и оптически активных ацетиламинокислот, их применение для лечения и/или профилактики нарушений, связанных с ожирением
RU2019109050A (ru) 2016-09-07 2020-10-08 Саниона А/С Композиции тезофензина
DE102017210141A1 (de) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Portion zur Bereitstellung tensidhaltiger Flotten
WO2020144146A1 (en) 2019-01-07 2020-07-16 Saniona A/S Tesofensine for reduction of body weight in prader-willi patients
EP4138830A1 (de) 2020-04-22 2023-03-01 Saniona A/S Behandlung von hypothalamischer fettsucht
TWI772928B (zh) * 2020-10-21 2022-08-01 行政院原子能委員會核能研究所 非放射性標準品β-CFT之製備方法
TW202409027A (zh) 2022-07-08 2024-03-01 丹麥商創始人製藥股份有限公司 用於女性性功能障礙的治療之化合物
CN115572289A (zh) * 2022-10-24 2023-01-06 龙曦宁（上海）医药科技有限公司 一种特索芬辛的合成方法
WO2024089247A1 (en) 2022-10-28 2024-05-02 Initiator Pharma A/S Compound for treatment of pain
WO2024146892A1 (en) 2023-01-03 2024-07-11 Initiator Pharma A/S Compound for treatment of erectile dysfunction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281130A (en) 1979-05-24 1981-07-28 Sterling Drug Inc. Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate
US5380848A (en) * 1990-08-09 1995-01-10 Research Triangle Institute Cocaine receptor binding ligands
US5496953A (en) * 1990-08-09 1996-03-05 Research Triangle Institute Cocaine receptor binding ligands
US5128118A (en) 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
WO1993009814A1 (en) * 1991-11-15 1993-05-27 Research Triangle Institute Cocaine receptor binding ligands
AU671163B2 (en) 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
AU672052B2 (en) 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
PL183025B1 (pl) * 1994-04-19 2002-05-31 Neurosearch As Pochodne tropanu, sposób ich otrzymywania i zawierające je kompozycje
GB9626611D0 (en) * 1996-12-20 1997-02-05 Unilever Plc Agglomerated silicas

Also Published As

Publication number Publication date
HK1018957A1 (en) 2000-01-14
DE69705608D1 (de) 2001-08-16
EE04751B1 (et) 2006-12-15
US6288079B1 (en) 2001-09-11
CN1211982A (zh) 1999-03-24
AU1794097A (en) 1997-09-10
NZ330886A (en) 1999-02-25
JP3238414B2 (ja) 2001-12-17
EE9800254A (et) 1999-02-15
CA2244773C (en) 2006-01-03
BG63945B1 (bg) 2003-07-31
IS4825A (is) 1998-08-17
CZ287007B6 (en) 2000-08-16
HUP9901199A2 (hu) 1999-08-30
PT885220E (pt) 2001-11-30
SI0885220T1 (en) 2001-12-31
EP1130020A1 (de) 2001-09-05
RU2167876C2 (ru) 2001-05-27
EP0885220B1 (de) 2001-07-11
BR9707636A (pt) 1999-07-27
AU720358B2 (en) 2000-06-01
SK281813B6 (sk) 2001-08-06
US6395748B2 (en) 2002-05-28
CZ252098A3 (cs) 1998-11-11
SK92998A3 (en) 1998-11-04
CA2244773A1 (en) 1997-08-28
PL185132B1 (pl) 2003-02-28
ZA971525B (en) 1997-10-21
US20010018444A1 (en) 2001-08-30
CN1077574C (zh) 2002-01-09
WO1997030997A1 (en) 1997-08-28
KR19990087127A (ko) 1999-12-15
TR199801641T2 (xx) 1998-11-23
DK0885220T3 (da) 2001-10-15
SG99853A1 (en) 2003-11-27
HUP9901199A3 (en) 2001-02-28
NO983877D0 (no) 1998-08-21
DE69705608T2 (de) 2002-05-16
JP2000504739A (ja) 2000-04-18
EP0885220A1 (de) 1998-12-23
US20020128284A1 (en) 2002-09-12
KR100446571B1 (ko) 2004-11-03
ES2159839T3 (es) 2001-10-16
UA49872C2 (uk) 2002-10-15
BG102637A (en) 1999-06-30
GR3036829T3 (en) 2002-01-31
IL125146A (en) 2002-03-10
NO318731B1 (no) 2005-05-02
IS1824B (is) 2002-10-01
IL125146A0 (en) 1999-01-26
NO983877L (no) 1998-08-21
PL328503A1 (en) 1999-02-01
HU228356B1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
DE69705608D1 (de) Tropanderivate, deren herstellung und verwendung
WO1999037623A3 (en) Sulphonamide derivatives for treatment of cns disorders
UA105629C2 (uk) Похідні арилсульфоніл піразолін карбоксамідину як антагоністи 5-нт6
MX2009003183A (es) Derivados de sulfonilpirazolincarboxamidina como antagonistas de 5-ht6.
WO2007028083A3 (en) 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
MX2009005509A (es) 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a).
NO20092688L (no) Forbindelser med en kombinasjon av cannabinoid-CB1 antagonisme og acetylcholinesteraseinhibering
MX2010009643A (es) Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a).
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
NZ592563A (en) 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
DE602006015193D1 (de) 8-alk0xy-4-methyl-3, 4-dihydr0-chinaz0lin-2-yl-amine und ihre verwendung als 5-ht5a-rezeptor-liganden
MX2010008239A (es) 2-aminoquinolinas.
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
UA98122C2 (ru) Производные сульфонилпиразол и сульфонилпиразолон карбоксамидина как антагонисты рецепторов 5-ht6
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
WO2000071533A3 (en) 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification